For healthcare professionals, this approval provides a new treatment option to help us address cardiovascular residual risk that remains for patients on current standard of care. Wegovy is now the first weight loss medication to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity or overweight, said John Sharretts, director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDAs Center for Drug Evaluation and Research
The BRAT diet The BRAT diet bananas, rice, applesauce, and toast includes bland, low-fibre foods that are often easier to digest while symptoms settle
The program enrolls over 5,800 participants total
Most weight loss peptides target one or some combination of these pathways
m - o , Total NAD + ( m) and NADH ( n ) levels as well as adjusted NADH from NAD-SILEC ( o ), (n = 6 for eGFP and n = 7 for A51 OE)